Raleigh-based Focal Medical, an oncology device company that received early funding from the North Carolina Biotechnology Center, has been acquired by a Florida biopharmaceutical company. Financial ...

Biogen is ramping up in RTP with a fresh $2 billion investment. © 2025 American City Business Journals. All rights reserved.

Biogen (NASDAQ:BIIB), and Ionis Pharmaceuticals (NASDAQ:IONS) announced that the European Medicines Agency (EMA) has given positive endorsements for their products. The EMA's Committee for Medicinal ...

Duke Energy predicts that in the next 15 years, Carolina customers’ annual electric use will increase by about 58,000 ...